Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 5, Pages 808
Publisher
MDPI AG
Online
2021-04-30
DOI
10.3390/v13050808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
- (2021) Mario Milani et al. ANTIVIRAL RESEARCH
- Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
- (2021) Zhuoming Liu et al. Cell Host & Microbe
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
- (2020) Mingxuan Xie et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy
- (2020) Danilo Licastro et al. JOURNAL OF VIROLOGY
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19
- (2020) Spencer J. Williams et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- THE CHOLESTEROL METABOLITE 27-HYDROXYCHOLESTEROL INHIBITS SARS-CoV-2 AND IS MARKEDLY DECREASED IN COVID-19 PATIENTS
- (2020) Alessandro Marcello et al. Redox Biology
- N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects
- (2020) Cristiane J. Nunes-Santos et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein response
- (2019) Tea Carletti et al. Nature Communications
- Cellular Targets for the Treatment of Flavivirus Infections
- (2018) Mohammad Khalid Zakaria et al. Frontiers in Cellular and Infection Microbiology
- Lysosomal storage diseases
- (2018) Frances M. Platt et al. Nature Reviews Disease Primers
- Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy
- (2016) Satoru Watanabe et al. ANTIVIRAL RESEARCH
- Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients
- (2016) Cynthia Sung et al. PLoS Neglected Tropical Diseases
- Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
- (2014) Xuesen Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
- (2014) Jenny G Low et al. LANCET INFECTIOUS DISEASES
- New Tags for Recombinant Protein Detection and O-Glycosylation Reporters
- (2014) Gianluca Petris et al. PLoS One
- Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
- (2013) Jinhong Chang et al. ANTIVIRAL RESEARCH
- Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus
- (2012) M. Fukushi et al. JOURNAL OF VIROLOGY
- Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein
- (2010) Gayle Ritchie et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started